Selphyl

Selphyl is a commercial-stage medical technology company specializing in regenerative medicine and aesthetic treatments through its proprietary Platelet-Rich Fibrin Matrix (PRFM) technology. The company's core product, the Selphyl System, allows healthcare providers to prepare a purified, autologous fibrin scaffold from a patient's blood, which facilitates the sustained release of essential growth factors. This technology is primarily marketed for skin rejuvenation, volume enhancement, and the treatment of androgenetic alopecia. By effectively removing red and white blood cells that can cause inflammation, Selphyl provides a more refined alternative to traditional Platelet-Rich Plasma (PRP) treatments. The company operates as a key player in the dermatology and plastic surgery markets.